Proliferative potential of human meningiomas of the brain: A cell kinetics study with bromodeoxyuridine

Cancer

Volumn 58, Issue 7, 1986, Pages 1466-1472

  Hoshino, Takao ^a   Nagashima, Tadashi ^a   Murovic, Judith A ^a   Wilson, Charles B ^a   Davis, Richard L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; MONOCLONAL ANTIBODY;

BRAIN MENINGIOMA; CELL GROWTH; CELL KINETICS; CENTRAL NERVOUS SYSTEM; CYTOLOGY; DIAGNOSIS; DNA SYNTHESIS; HEMANGIOPERICYTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MENINGIOMA; NERVOUS SYSTEM; PRIORITY JOURNAL; TISSUE SECTION; TUMOR RECURRENCE;

ADULT; AGED; BROMODEOXYURIDINE; CELL CYCLE; CHILD; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; STAINING AND LABELING;

EID: 0022549117     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19861001)58:7<1466::AID-CNCR2820580715>3.0.CO;2-W     Document Type: Article

References (30)

1. Histological types of meningiomata and a comparison of their behavior in tissue culture with that of certain normal human tissues
2. The study of tissue cultures of tumours of the nervous system
3. In Vitro cultures of human meningioma tissue
4. Development of a clonogenic cell assay for human brain tumors
5. Immuno‐cytochemical demonstration of S‐phase cells by anti‐bromodeoxyuridine monoclonal antibody in human brain tumor tissues
6. Monoclonal antibody to 5‐bromo‐and 5‐iododeox‐yuridine: A new reagent for detection of DNA replication
7. The effects of incorporation of 5‐halogenated deoxyuridine into the DNA of eukaryotic cells
8. In situ cell kinetic studies on human neuroectodermal tumors with bromodeoxyuridine labeling
9. Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine)
10. Radiosensitization of malignant brain tumors with bromouridine (thymidine analogue)
11. Intra‐arterial 5‐bromodeoxyuridine and x‐ray therapy
12. Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR)
13. A phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation
14. Pharmacological evaluation of intravenous delivery of 5‐bromodeoxyuridine to patients with brain tumors
15. Cell kinetic analysis of human malignant brain tumors (gliomas)
16. A cell kinetic study on medulloblastomas
17. The proliferative potential of human pituitary tumors in situ
18. An autoradio‐graphic study of human gliomas: Growth kinetics of anaplastic astro‐cytoma and glioblastoma multiforme
19. Histological subtypes and prognostic problems in meningiomas
20. Malignant meningiomas clinical and pathological features
21. The growth rate of intracranial meningiomas and its relation to histology
22. The recurrence of intracranial meningiomas after surgical treatment
23. The prognosis in meningiomas
24. The recurrence of intracranial meningiomas
25. The recurrence of intracranial meningiomas after surgical treatment
26. Prediction of recurrence in meningiomas after surgical treatment
27. Importance of meningioma: Clinico‐epide‐miologic and histologic studies